Our staff hold a wide variety of knowledge and expertise.
We have more than 300 scientists and support members contributing to our world-class research. Dedicated teams work around the clock seeking new opportunities that can lead to novel drugs, vaccines and diagnostics, translating our research into tangible benefits for the global community. Ground-breaking translational research requires a host of exceptional people coupled with state-of-the-art facilities and equipment.
Our Leadership Team
Our Research leaders
Principal Research Leaders

Distinguished Professor Mark von Itzstein AO
FAA FAHMS FRACI NHMRC Investigator L3
Cancer; Infectious Diseases; Metabolic Disease

Professor Michael Jennings
FAHMS FASM FAAM NHMRC Investigator L3
Infectious Diseases

Professor Michael Good AO
FTSE FAHMS NHMRC Investigator L3
Infectious Diseases

Professor Daniel Kolarich
Cancer, Disease Glycobiology, Glycomics, Glycoproteomics, Mass Spectrometry
Research Leaders
Board of Advice

The Honourable Robert Borbidge AO
Chair

Pat Crotty
Deputy Chair

Luke O’Dwyer

Paul Sanders

Christine Lohman MBA, FAICD, FPRIA

Rachel Hancock

Clayton Glenister

Karen Phillips

Lucy Cole

William Matthews
